A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of ...

Results from the first randomized trial of Impella pumps during complex stent procedures, published in the New England ...

Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...

Trial in progress: A phase 3 randomized study of low-dose intralesional cemiplimab versus primary surgery for patients with early-stage cutaneous squamous cell carcinoma (CLEAR CSCC). This is an ASCO ...

Findings come amid growing off-label prescribing of GLP-1 drugs for addiction ...

Reducing plastic in food prep and storage may lower harmful chemical exposure in just seven days. Ultra-processed foods and ...

Phase 1 clinical update of IMA203, an autologous TCR-T targeting PRAME in patients with PD1 refractory metastatic melanoma. Overall survival according to time-of-day of combined immuno-chemotherapy ...

A four-condition crossover design (hydromorphone, dronabinol, combination, placebo) in 21 participants showed no additive or ...

The agency explicitly stated that the trial’s current primary endpoint is “not an appropriate endpoint to demonstrate efficacy.” ・As a result, the FDA no longer considers the study to be “pivotal.” ...